Cellemedy
- Headquarters
- Gyeonggi-do
- Business Model
- B2B
- Website
- cellemedy.com
About
Korean biotech developing next-generation therapeutic proteins to replace conventional antibody-based treatments.
Summary
Cellemedy is a Biotech company based in Gyeonggi-do, South Korea.
Similar Companies
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...

China's leading mRNA biotech company developing therapeutics for cancer and infectious diseases.
Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...
Clinical-stage programmable cell therapy company developing engineered T-cell therapies for solid...
Clinical-stage biotech developing next-generation CAR T-cell therapies for cancer patients aiming...

Clinical-stage biotechnology company developing T-cell engager therapeutics for autoimmune and in...